The chemical cross-linking of β-cyclodextrin (β-CD) with ethylenediaminetetraacetic dianhydride (EDTA) led to branched polymers referred to as cyclodextrin nanosponges (CDNSEDTA). Two different preparations are described with 1:4 and 1:8 CD-EDTA molar ratios. The corresponding cross-linked polymers were contacted with 0.27 M aqueous solution of ibuprofen sodium salt (IP) leading to homogeneous, colorless, drug loaded hydrogels.
Introduction
There is a growing interest in the design and formulation of polymeric systems capable of entrapping, via non-covalent interactions, small molecules with potential biochemical activity. Such materials are expected to find applications in the transport of the active principle to selective target and release upon the action of external stimuli, such as pH variations, temperature, etc. In this context, hydrogels turned out to be versatile and powerful materials for nanomedicine in view of controlled release of drugs 1 . The formation of polymeric hydrogels can be achieved by interconnecting the macromolecular chains by i) physical, non-covalent interactions such as hydrogen bonds, ii) covalent cross-linking of the chains leading to a three-dimensional network able to swell in the presence of an aqueous solution or iii) a combination of the two mentioned methods [2] [3] [4] .
A particularly versatile class of three-dimensional, swellable polymers for the encapsulation of organic and inorganic species can be obtained starting from natural β-cyclodextrin (β-CD) via condensation with suitable, activated derivatives of a tetracarboxylic acid [5] [6] [7] [8] giving rise to cyclodextrin nanosponges (CDNS). The synthesis, characterization and application of CDNS is a consolidated research theme of our group. The past few years' results indicate that CDNS show intriguing properties of swelling, absorption/inclusion of chemicals, and release of small drug molecules, with applications in controlled release of pharmaceutical active ingredients [9] [10] [11] and environmental chemistry , gels and swellable polymers 20, 21 . Indeed, the experimental setup combining HR-MAS NMR spectroscopy and the PGSE pulse sequence provides a unique opportunity to observe the solute molecules in the host's molecular environment. Important data on the transport properties of the entrapped drug molecule within a gel matrix can thus be obtained. High quality experimental data can thus be obtained allowing a more rational design of nanostructured host-guest systems.
In the present work we describe the detailed protocols for the following steps: i) synthesis and purification of two different formulation of CDNS cross-linked with EDTA polymers (Figure 1) , referred to as CDNSEDTA, and characterized by different CD/cross linker molar ratio: 1:4 (CDNSEDTA 1:4) and 1:8 (CDNSEDTA 1:8); ii) the preparation of drug-loaded hydrogels for both CDNSEDTA 1:4 and CDNSEDTA 1:8. In this step we used, as model drug molecule, the popular non-steroidal anti-inflammatory ibuprofen sodium salt (IP); iii) the thorough investigation of the transport properties of IP within the CDNSEDTA hydrogels via PGSE-HRMAS NMR spectroscopy. The method we propose here is based on the measurement of the mean square displacement (MSD) of the encapsulated drug within the hydrogel followed by the analysis of the time dependence of the MSD.
We wish to stress that the methodology outlined above -which is focused on the time dependence of the drug's MDS in the matrix -provides a broader spectrum of information compared to the consolidated methodology based on the determination of the drug's diffusion coefficient only. We recently demonstrated 21 that this approach allowed for the discrimination of normal and anomalous diffusion regimes experienced by IP confined in CDNS hydrogels.
We thus believe that the step-by-step description of polymer synthesis/purification, formation of the drug-loaded hydrogels, HR-MAS NMR characterization and data processing of MDS data, is a powerful toolkit for scientists interested in characterizing nanostructured systems for the confinement and release of small molecules.
Protocol

Synthesis of CDNSEDTA Polymers
1. Dry β-cyclodextrin (β-CD) in oven at 80 °C for 4 hr before use. Dry 500 ml of dimethylsulfoxide (DMSO) and 100 ml of triethylamine (Et 3 N) over molecular sieves (4 Å) for 24 hr before using them in the protocol. 
HR-MAS NMR Measurements
2. Add 20 mg of CDNSEDTA 1:4 and 2 mg of anhydrous Sodium carbonate (Na 2 CO 3 ) to 150 µl of the solution prepared at the point 2.1.1) into a 2 ml glass vial. Mix the content of the vial with a small spatula in order to homogenize it. Wait 2 hr before using the gel formed with this procedure. Repeat this point for the CDNSEDTA 1:8 polymer. 3. Insert the gel in a 5mm NMR rotor suitable for HR-MAS NMR experiments using a small spatula. The total amount of gel to use depends on the internal volume of the rotor (12 μl recommended).
HR-MAS
1
H NMR Experiments 1. Set the following instrumental parameters: rotor spinning speed of 4 KHz at the MAS pneumatic control unit, sample temperature at 305 K in the variable temperature unit. 2. Acquire the 1 H HR-MAS NMR spectra of ibuprofen in CDNSEDTA (1:4) and CDNSEDTA (1:8) polymer systems using a conventional one pulse sequence on the proton resonance.
1. Create a new data set. Click on the "AcquPars" tab. Select the PULPROG: zg. 2. Select the number of scans (NS = 4) and the time delay between them (D1 = 5 sec).Set the spectral width (SW = 8 ppm), the time domain (TD = 16K) and the receiver gain (RG = 32). 3. Type "zg" on the console and there will be a free induction decay (FID) on the screen. To process the data click on the "ProcPars" tab. Set the spectral size (SI = 32K), an exponential multiplication window function (WDW = EM) and line broadening (LB = 1). Type "ft" to perform the Fourier transformation. Phase the spectrum using the phase tab on the screen. Obtain a high resolution well resolved spectrum. 3. HR-MAS 1 H NMR PGSE Experiments NOTE: The PGSE experiments are performed using the BPPLED pulse sequence 18 reported in Figure 2 . This is a pseudo two-dimensional experiment with a gradient ramp increasing linearly from 2% to 100% in the indirect dimension. The signal intensity is attenuated depending on the diffusion time Δ and the gradient pulse δ. The optimization of these parameters is required before running properly a PGSE experiment. The optimization is done by running a few 1D measurements in which Δ is kept constant, while δ is varied. 1. Parameters Optimization 1. Create a new data set -experiment number 1. Click on the "AcquPars" tab. Select the PULPROG: ledbpgp2s1d the 1D pulse sequence for diffusion optimization. 2. Select the number of scans (NS = 16) and the time delay between them (D1 = 10 sec). Set the spectral width (SW = 8 ppm), the time domain (TD = 16K) and the receiver gain (RG = 32). 3. Set Δ (D20 in the sequence) equal to a constant value and δ (p30) to a trial value. Start value Δ = 50 msec, δ = 3 msec (maximum allowed value for high resolution instruments). 4. Read the value of spectral frequency (SFO1) from the 1 H experiment and use now this value. Set the GPZ6 gradient strength to 2%. Repeat step 2.2.2.3. Use this spectrum as reference for the optimization. 5. In the same data set create the experiment number 2. Observe all the experimental parameters. Increase the GPZ6 gradient strength to 95%. Repeat step 2.2.2.3. Compare this spectrum with the reference spectrum using the dual display icon and observe the change in the signal intensity. NOTE: A well attenuated spectrum should have about 5% residual signal intensity compared with the reference spectrum. If the signal intensity is lost, reduce the value of δ and restart the section 2.3.1 procedure from point 2.3.1.3 until the right value for δ is found. 6. Repeat the parameters optimization procedure in section 2. 2. Acquisition of the 2D Diffusion Data Set 1. In the same data set create the experiment number 3, all the 1D experimental parameters will be loaded. Type "eda". Select the PULPROG: ledbpgp2s the 2D pulse sequence and change the parmode to 2D. 2. Set FnMODE=QF. Set the time domain TD in F2 dimension equal to 32, the number of gradient steps. All the other parameters are set correctly. Type "DOSY" and the gradient ramp will be generated and stored in a file. The start and final values of the ramp (2 -95) are given as input parameters. The acquisition is now started.
4. Data Processing 1. Type "xf2" to execute the Fourier transformation in the F2 dimension. Type "abs2" to perform the baseline correction in the F2 dimension. Type "setdiffparm" to recall the experimental parameters (Δ, δ, and gradient list) for the next processing step. 2. Click "T1/T2 relaxation module" in the analysis tab and define the peaks to be fitted using the first spectrum of the 2D experiment.
Define the peak ranges and execute the fitting. The signal intensities at each applied gradient step are obtained. NOTE: Depending on the value of the exponent α, the diffusion regime is defined as: i) isotropic unrestricted diffusion for α = 1, ii) anomalous subdiffusive regime for 0 < α < 1, iii) anomalous superdiffusive regime for α > 1.
Representative Results
We first applied this methodology to the IP drug molecule dissolved in water solution in order to verify the viability of this approach. A full description of the representative results can be found in ref. 21 . Rather, we will focus here on the methodological aspects and the nuts-andbolts approach to data collection and data analysis. The experimental procedure has been used to study the diffusion motion of IP drug molecule encapsulated in CDNSEDTA 1:4 and CDNSEDTA 1:8 hydrogels. 
Discussion
We present an experimental methodology to determine the diffusion regime of a small drug molecule encapsulated inside two representative formulations of CDNSEDTA hydrogels. HR-MAS PGSE NMR allows the determination of the mean square displacement of small molecules in a given diffusion time (in the range of a few milliseconds up to second), then monitoring distances in the micrometer scales. In the range observed (50 -170 msec) only one type of motion is observed for each studied system. It should be stressed, however, that for longer observation times the transition between different diffusion regimes can be observed 22 . Thus, the results reported here are referred to the time-scale dictated by the hardware available for the experiments and with the instrumentation at our disposal.
For each step of this work -polymer synthesis, hydrogel loading, HR-MAS NMR data collection and processing, we list here three main problems and the corresponding solution.
The rotor filling is the critical step for sample preparation (see 2.1.3). The presence of air bubbles must be avoided. If bubbles are present, an incorrect spinning is generally detected (e.g., maximum spinning rate not reached, spinning does not start at all, not uniform spinning rate) . In the case of non-uniform spinning or failure to start spinning the rotor, extract the sample and repeat the rotor filling more carefully.
NMR Data analysis
In point 2.4.2 it is described how to obtain MSD values from the intensity decay curves. Very often the experimental points do not seem to follow a completely linear trend vs q 2 . In such case, use only the linear part of the dataset and run the linear regression.
The obtained results may be summarized as follows: D 2 O solution In this simple case, the MSD shows linear dependence on the diffusion time Δ and the IP molecule undergo unrestricted diffusion in solution. This case is generally referred to as "normal" diffusion. The self-diffusion coefficient can be directly estimated from a single measurement at any observation time t d . In a general approach, the measurement of diffusivity in isotropic, molecular solvent may be taken as reference to investigate the influence of the scaffold on the transport properties of the encapsulated guest.
CDNSEDTA 1:4 polymer
The entrapment of IP into the polymeric hydrogel affects the drug transport properties compared to the water solution. A subdiffusive motion with α = 0.64 is detected. The translational motion of the drug molecules is hampered by the presence of nanopores of different sizes originated during the cross-linking process.
CDNSEDTA (1:8) polymer
In this case the unexpected value α = 1.06 is determined, thus indicating a slightly superdiffusive motion regime. Accordingly, an acceleration effect on the particles MSD is observed ( Table 1) . This effect can be ascribed to the negative electric potential of the polymeric backbone generated by the carboxylic groups negatively charged in some parts of the CDNS polymer. The electrostatic interaction with the negatively charged IP molecules provides the driving force for the superdiffusive component of the motion.
The methodology described here provided information on the diffusion regime experienced by the drug in the different molecular environment corresponding to the two hydrogels formulation through the value of the α exponent discussed above. This approach is of general applicability and can be confidently proposed as investigating tool of the transport properties of the encapsulated drug, with interesting fall-out for design of drug delivery-controlled release systems. However, it should be kept in mind that the results presented here suffer from the hardware limitation of the instrumentation used.
Additionally, some limiting factors for the general applicability of the method could be hypothesized: the preparation of drug-loaded gels with lipophilic and/or non-charged drugs, the possibility of strong adhesion of the drug to the polymer backbone, thus leading to unresolved NMR signals and difficulty in pH control. Finally, it should be mentioned that the diffusion NMR data span the ms time-scale, while the classic in vitro drug release experiments rely upon much longer time-windows. This is an open point object of research and debate. As a possible contribution to address this issue, we have recently examined the diffusion data of a model drug in library of carbohydrate-based hydrogels and derived a mathematical model connecting the measurements at molecular level with the kinetic data 23 . Larger collections of diffusion data and broader libraries of scaffolds are under investigation to refine and validate the model.
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